These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 8882310)
1. Environmental pathogenesis of human retroviruses. Montagnier L AIDS Res Hum Retroviruses; 1996 Mar; 12(5):357-9. PubMed ID: 8882310 [No Abstract] [Full Text] [Related]
3. In HIV vaccine efforts, new strategies and patience are needed in equal measure. Stephenson J JAMA; 2002 Dec; 288(21):2671-2. PubMed ID: 12460070 [No Abstract] [Full Text] [Related]
4. RV144: old vs. new. Weiner DB Hum Vaccin; 2010 Feb; 6(2):159-61. PubMed ID: 20431335 [No Abstract] [Full Text] [Related]
6. An HIV vaccine--evolving concepts. Johnston MI; Fauci AS N Engl J Med; 2007 May; 356(20):2073-81. PubMed ID: 17507706 [No Abstract] [Full Text] [Related]
7. Role of polymorphonuclear leukocytes in infection by retroviruses with emphasis on the human immunodeficiency virus. Mertins SD; Ortona L; Cauda R Viral Immunol; 1990; 3(3):173-94. PubMed ID: 2175193 [TBL] [Abstract][Full Text] [Related]
8. Proceedings of the 2nd International Summit Meeting on Immunological Correlates of Protection from HIV Infection and Disease. Oxford, United Kingdom, 17-20 April 1998. Immunol Lett; 1999 Mar; 66(1-3):1-228. PubMed ID: 10357622 [No Abstract] [Full Text] [Related]
10. Improving defences at the portal of HIV entry: mucosal and innate immunity. Shattock RJ; Haynes BF; Pulendran B; Flores J; Esparza J; PLoS Med; 2008 Apr; 5(4):e81. PubMed ID: 18384232 [TBL] [Abstract][Full Text] [Related]
11. Researchers announce first correlates of protection for HIV vaccine. Roehr B BMJ; 2011 Sep; 343():d5880. PubMed ID: 21920885 [No Abstract] [Full Text] [Related]
12. Cellular response. Are antibodies the most effective defense against AIDS? Beardsley T Sci Am; 1992 Dec; 267(6):42-4. PubMed ID: 1439714 [No Abstract] [Full Text] [Related]
13. [PolyEnv, a new strategy in the development of anti-HIV vaccines]. Molina CN Sidahora; 2001 Oct; ():7-11. PubMed ID: 11776248 [No Abstract] [Full Text] [Related]
15. The RV144 Thai HIV vaccine trial. Plotkin SA Hum Vaccin; 2010 Feb; 6(2):159. PubMed ID: 20431337 [No Abstract] [Full Text] [Related]
16. Correlates of protection and HIV vaccine development. Akpogheneta O Lancet Infect Dis; 2011 Nov; 11(11):814-5. PubMed ID: 22167821 [No Abstract] [Full Text] [Related]
17. Antibodies and resistance to natural HIV infection. Nabel GJ; Sullivan NJ N Engl J Med; 2000 Oct; 343(17):1263-5. PubMed ID: 11071680 [No Abstract] [Full Text] [Related]
18. [HIV and vaccines]. Payen MC Acta Urol Belg; 1993; 61(1-2):607-14. PubMed ID: 8517278 [No Abstract] [Full Text] [Related]
19. An HIV vaccine--challenges and prospects. Johnston MI; Fauci AS N Engl J Med; 2008 Aug; 359(9):888-90. PubMed ID: 18753644 [No Abstract] [Full Text] [Related]
20. Infectious disease. An enterprising time for HIV vaccine research. Cohen J Science; 2012 Sep; 337(6101):1446. PubMed ID: 22997300 [No Abstract] [Full Text] [Related] [Next] [New Search]